NDC 51754-1007

ELCYS

Cysteine Hydrochloride

ELCYS is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Exela Pharma Sciences, Llc. The primary component is Cysteine Hydrochloride.

Product ID51754-1007_3f3dc2d1-9383-4c95-b97a-3e25c588d8a4
NDC51754-1007
Product TypeHuman Prescription Drug
Proprietary NameELCYS
Generic NameCysteine Hydrochloride
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2019-05-28
Marketing CategoryNDA / NDA
Application NumberNDA210660
Labeler NameExela Pharma Sciences, LLC
Substance NameCYSTEINE HYDROCHLORIDE
Active Ingredient Strength10 mg/mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 51754-1007-1

10 mL in 1 VIAL (51754-1007-1)
Marketing Start Date2019-05-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51754-1007-1 [51754100701]

ELCYS INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA210660
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2019-05-28

NDC 51754-1007-3 [51754100703]

ELCYS INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA210660
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2019-05-28

Drug Details

Active Ingredients

IngredientStrength
CYSTEINE HYDROCHLORIDE10 mg/mL

OpenFDA Data

SPL SET ID:e7652275-1c53-490c-82ad-e63867df5788
Manufacturer
UNII

NDC Crossover Matching brand name "ELCYS" or generic name "Cysteine Hydrochloride"

NDCBrand NameGeneric Name
51754-1007ELCYSCysteine Hydrochloride
0338-9645CYSTEINE HYDROCHLORIDEcysteine hydrochloride
76014-006Nouresscysteine hydrochloride

Trademark Results [ELCYS]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ELCYS
ELCYS
88350906 5899186 Live/Registered
Exela Holdings, Inc.
2019-03-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.